EPISODE · Mar 2, 2026 · 50 MIN
Breaking Ground in Gastroesophageal Adenocarcinoma: First-Line Anti-HER2 Therapy for Advanced Disease
from Keeping Current CME
Do you know how many different types of anti-HER2 therapies are in clinical trials for gastroesophageal adenocarcinoma (GEA)? Credit available for this activity expires: 02/27/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/breaking-ground-gastroesophageal-adenocarcinoma-first-line-2026a10005tj?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
Breaking Ground in Gastroesophageal Adenocarcinoma: First-Line Anti-HER2 Therapy for Advanced Disease
0:00
50:25
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 50 minutes long.
When was this Keeping Current CME episode published?
This episode was published on March 2, 2026.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!